{
  "abstract": "Introduction Chronic obstructive pulmonary disease (COPD) – a progressive disease characterised by persistent airflow limitation – causes a substantial healthcare burden. This analysis aims to quantify the burden of COPD in secondary care settings in England and the impact of seasonality and deprivation.Methods This was an exploratory, retrospective analysis of the Hospital Episode Statistics (HES) data for patients with a primary diagnosis of COPD (J44.0, J44.1, J44.9) admitted between January 2023 and December 2024. Hospital admissions, length of stay (LOS), and costs were calculated; stratifications included month, patient age, and index of multiple deprivation (IMD). Longitudinal analysis was conducted; patients with an admission for COPD within the 2023 calendar year (index admission) were followed for 1-year following their index date; repeat admissions for COPD in the year after admission were assessed.Results Across 2023 and 2024 there were 153,800 patients identified in England accounting for 241,925 admissions from COPD, costing £673,076,864, with an average LOS of 6.39 days and cost per admission of £2,782. There were 46,405 admissions in Winter (December 23-March 24) compared with 26,105 in Summer (June-September 24). Monthly admission counts are shown in figure 1A. Between October 2023 and December 2024, patients in the most deprived IMD quintile had the highest number of admissions and greatest cost (figure 1B). In 2024, patients aged <65 represented 23% of the admissions across England (average LOS 5.03 days). Longitudinal analyses showed that of 86,210 patients in the cohort in 2023, 26,460 (30.7%) were readmitted within 1 year for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD); of these patients, 12,425 (47%) had at least two admissions and 6,920 (26.2%) had three admissions.Abstract P10 Figure 1Conclusions Burden is influenced by seasonality, with 35% more admissions in winter compared with summer. The most deprived are disproportionately impacted, accounting for three times more admitted patients than the least deprived quintile. Furthermore, nearly a quarter of patients admitted were of working age. This analysis demonstrates that COPD continues to represent a substantial burden on patients, the NHS, and society; there is an urgent need to focus the optimisation of care on these high burden groups.",
  "authors": [
    {
      "affiliations": [
        "King’s Centre for Lung Health, Peter Gorer Department of Immunobiology, King’s College London, London, UK"
      ],
      "name": "REK Russell"
    },
    {
      "affiliations": [
        "King’s Centre for Lung Health, Peter Gorer Department of Immunobiology, King’s College London, London, UK"
      ],
      "name": "M Bafadhel"
    },
    {
      "affiliations": [
        "AstraZeneca UK, London, UK"
      ],
      "name": "C Lupton"
    },
    {
      "affiliations": [
        "AstraZeneca UK, London, UK"
      ],
      "name": "M Watt"
    },
    {
      "affiliations": [
        "AstraZeneca UK, London, UK"
      ],
      "name": "C Thomas"
    }
  ],
  "title": "P10 Breathless systems: COPD pressures in hospitals across England",
  "uid": "1401a0b9-8946-59d7-9659-b06594f1f9cc"
}